Penicillin V as first-line treatment of pneumonia in primary care: a registry-based study
Clinical Microbiology and Infection · 2026
DOI: 10.1016/j.cmi.2025.08.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Olof Cronberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Växjöhälsan Primary Healthcare Centre, Växjö, Sweden; Department of Research and Development, Region Kronoberg, Växjö, Sweden; Department of Clinical…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Penicillin V, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Läkaresällskapet, Region Jönköpings läns.
Abstract (Originalsprache)
OBJECTIVES: Penicillin V (PcV) is considered the first-line treatment for community-acquired pneumonia in Scandinavian countries, although data supporting this recommendation are scarce. Thus, this study aimed to compare PcV and amoxicillin regarding the risk of treatment failures in children aged >5 years and adults treated for pneumonia in primary care. METHODS: In this retrospective study of healthcare registry data from four regions in Sweden with 2.3 million inhabitants, we included 34 306 primary care cases of pneumonia from February 12, 2018 to December 3, 2021. Adjusted odds ratios (aORs) and 95% CIs for treatment failure days 1 to 28 (primary composite endpoint: hospitalization for lower respiratory tract infections [LRTI] or all-cause mortality; and secondary endpoint: antibiotic switch) were calculated using logistic regression analysis. A propensity score matched analysis was conducted. RESULTS: PcV was prescribed in 19 761 cases, amoxicillin in 2363 cases, doxycycline in 9830 cases, and other antibiotics in 2352 cases. Hospitalization for LRTI or all-cause mortality occurred in 4.9% of cases treated with amoxicillin vs. 3.8% of cases treated with PcV (aOR, 1.07; 95% CI, 0.87-1.32). Antibiotic switch occurred in 8.9% of cases treated with amoxicillin vs. 14% of cases treated with PcV (aOR, 0.58; 95% CI, 0.50-0.67). The corresponding ORs of the propensity score match analysis were 1.13 (95% CI, 0.86-1.49) for hospitalization for LRTI or all-cause mortality and 0.55 (95% CI, 0.45-0.65) for antibiotic switch. CONCLUSIONS: This study showed no difference in risks of hospitalization for LRTI or all-cause mortality between PcV and amoxicillin for pneumonia in primary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Växjöhälsan Primary Healthcare Centre, Växjö, Sweden; Department of Research and Development, Region Kronoberg, Växjö, Sweden; Department of Clinical Sciences, Family Medicine and Community Medicine, Lund University, Ma…
- Department of Clinical Sciences, Family Medicine and Community Medicine, Lund University, Malmö, Sweden.
- Department of Health, Medicine and Caring Sciences, Linköping University, Sweden.
- Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
- Department of Clinical Sciences, Family Medicine and Community Medicine, Lund University, Malmö, Sweden; Futurum, Region Jönköping County and Department of Health, Medicine and Caring Sciences, Linköping University, Lin…
Förderung
- Svenska Läkaresällskapet
- Region Jönköpings läns
Zitieren
APA
Cronberg, O., Tyrstrup, M., Beckman, A., Carlsson, S., Ekblom, K., Moberg, A., & Hedin, K. (2026). Penicillin V as first-line treatment of pneumonia in primary care: a registry-based study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.08.016
Vancouver
Cronberg O, Tyrstrup M, Beckman A, Carlsson S, Ekblom K, Moberg A, et al. Penicillin V as first-line treatment of pneumonia in primary care: a registry-based study. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2025.08.016
BibTeX
@article{Cronberg2026,
author = {Cronberg, Olof and Tyrstrup, Mia and Beckman, Anders and Carlsson, Sara and Ekblom, Kim and Moberg, Anna and Hedin, Katarina},
title = {Penicillin V as first-line treatment of pneumonia in primary care: a registry-based study},
journal = {Clinical Microbiology and Infection},
year = {2026},
doi = {10.1016/j.cmi.2025.08.016}
}
EUVIMED